IP Library Granted Patent US 10,470,861
Granted Patent B2
US 10,470,861 · App. 13/520,138 · Granted Nov 12, 2019

Elongate implant system and method for treating pelvic conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,470,861
App. No.
13/520,138
Granted
Nov 12, 2019
Kind
B2
Abstract

Implant systems can include one or more needles, such as those used in pelvic floor repair procedures, and one or more elongate implants. A syringe or similar style hollow needle can be used to deliver the elongate mesh or other implant devices through one or more small stab incisions into the target tissue location inside the pelvis, proximate the vagina. The implant devices can be placed upon insertion through the incisions to engage and pull or tighten support tissue, such as the endopelvic fascia, pubocervical fascia, rectovaginal fascia, levator muscles, or other supportive muscles or tissue within the pelvis of the patient.

Claims (15)

1. A method of treating a pelvic disorder in a patient, comprising:

providing a delivery tool having a handle and a needle, the needle being coupled to the handle, the needle including an internal lumen, the needle including a distal portion, the distal portion having a distal tip for creating external stab incisions;

providing a plurality of elongate rod implants including a first elongate rod implant, a second elongate rod implant, and a third elongate rod implant;

making a plurality of external stab incisions in a patient, proximate a vagina, with the needle of the delivery tool, the plurality of external stab incisions including a first external stab incision at a first location, a second external stab incision at a second location, and a third external stab incision at a third location, the first location, the second location, and the third location being at different locations;

providing the first elongate rod implant within the internal lumen of the needle of the delivery tool;

inserting the distal portion of the needle within the first external stab incision;

deploying the first elongate rod implant from the internal lumen such that the first elongate rod implant extends linearly with respect to the vagina of the patient;

providing the second elongate rod implant within the internal lumen of the needle;

inserting the distal portion of the needle within the second external stab incision;

deploying the second elongate rod implant from the internal lumen of the needle such that the second elongate rod implant extends linearly within a pelvic region, adjacent and proximate the first elongate rod implant, providing the third elongate rod implant within the internal lumen of the needle;

inserting the distal portion of the needle within the third external stab incision; and

deploying the third elongate rod implant from the internal lumen of the needle such that the third elongate rod implant extends linearly within the pelvic region.

2. The method of claim 1 , wherein making the plurality of external stab incisions includes making the plurality of external stab incisions anterior to the vagina.

3. The method of claim 1 , wherein making the plurality of external stab incisions includes making the plurality of external stab incisions posterior to the vagina.

4. The method of claim 1 , wherein the first elongate rod implant includes a first end portion and a second end portion, and the first elongate rod implant includes a first tissue anchor coupled to the first end portion, and a second tissue anchor coupled to the second end portion.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043777/0895 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043778/0167 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA; PREVIOUSLY RECORDED ON REEL 037300 FRAME 0199. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Feb 25, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037916/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0745 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0919 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0199 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2012
From: KHAMIS, CHAOUKI A.; ALEXANDER, JAMES A.
To: AMS RESEARCH CORPORATION
Reel/Frame 028473/0283 →